Janssen terminates deal with Chi-Med

Hutchison China MediTech Ltd. (AIM:HCM) said the Janssen Pharmaceutical Inc. unit of Johnson & Johnson (NYSE:JNJ) terminated an agreement with its Hutchison MediPharma Ltd. R&D unit to develop HMPL-507, a small molecule against an undisclosed target in the area of inflammation and immunology. ...